Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2020 - 2024)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Amortizatization of Intangibles came in at $76000.0 in Q3 2024, down 62.75% year-on-year from $204000.0 in Q4 2023, and down 42.42% quarter-over-quarter from $132000.0 in Q2 2024.
Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2020 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $76000.0 for Q3 2024.
- On a quarterly basis, Amortizatization of Intangibles fell 62.75% year-over-year to $76000.0 in Q3 2024; TTM through Jun 2025 was $76000.0, a 89.36% decrease from a year earlier, with the FY2024 full-year figure at $396000.0, down 51.94% from the prior year.
- Amortizatization of Intangibles slipped to $76000.0 in Q3 2024 per CRBP's latest filing, from $132000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $343193.0 in Q2 2021 and bottomed at $901.0 in Q1 2021.
- The 5-year median for Amortizatization of Intangibles is $185201.5 (2022), against an average of $177219.1.
- Across the five-year window, Amortizatization of Intangibles jumped 19533.85% in 2022 and slumped 62.75% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $172415.0 in 2020, then tumbled by 45.17% to $94535.0 in 2021, then jumped by 114.32% to $202611.0 in 2022, then retreated by 6.22% to $190000.0 in 2023, then sank by 60.0% to $76000.0 in 2024.
- Per Business Quant, the three latest CRBP Amortizatization of Intangibles figures stand at $76000.0 (Q3 2024), $132000.0 (Q2 2024), and $188000.0 (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Jun 30, 2023 | 228,877.00 |
| Jun 30, 2023 | 228,877.00 |
| Mar 31, 2023 | 201,123.00 |
| Mar 31, 2023 | 201,123.00 |
| Dec 31, 2022 | 202,611.00 |
| Dec 31, 2022 | 202,611.00 |
| Sep 30, 2022 | 182,403.00 |
| Sep 30, 2022 | 182,403.00 |
| Jun 30, 2022 | 180,563.00 |
| Jun 30, 2022 | 180,563.00 |